Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells

Gabriella Horvath, Reka Brubel, Krisztina Kovacs, D. Reglodi, Balazs Opper, A. Ferencz, Peter Szakaly, Eszter Laszlo, Lidia Hau, P. Kiss, A. Tamás, B. Rácz

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Oxidative stress plays an important role in various renal and hepatic pathologies, and reduction of oxidative stress-induced processes is an important protective strategy in tissues of diverse origins against harmful stimuli. Pituitary adenylate cyclase activating polypeptide (PACAP) is a well-known cytotrophic and cytoprotective peptide. PACAP promotes cell survival in numerous cells and tissues exposed to various stimuli. Protective effects of PACAP have been shown in the kidney, but it is not known whether PACAP is protective against oxidative stress in renal cells. Little is known about the effects of PACAP in the liver. The aim of the present study was to investigate whether PACAP is protective against oxidative stress in primary rat kidney cell culture and whether PACAP has any effect on cell survival in human WRL-68 hepatocytes and HEP-G2 hepatocellular carcinoma cells subjected to oxidative stress. Cells were exposed to various concentrations of H2O2 with or without PACAP co-treatment and cell viability was evaluated with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide test (MTT). We found that oxidative stress induced a significant decrease in cell viability in both cell lines. PACAP could dose-dependently increase the percentage of living cells in kidney cells, but it failed to do so in hepatocytes. Given the survival-promoting effects of PACAP against oxidative stress in rat kidney, we conducted a further experiment to determine whether PACAP influences the markers of oxidative stress in vivo. We have proven earlier that PACAP was effective in kidney ischemia/reperfusion injury in vivo. In the present study, we determined the levels of the oxidative stress marker malondialdehyde and the activity of the scavenger molecules glutathione (GSH) and superoxide dismutase (SOD) following kidney ischemia/reperfusion in rats. We found that PACAP significantly increased the level of GSH and counteracted the marked reduction of SOD activity after ischemia/reperfusion in vivo. In summary, the present study showed that while PACAP was able to significantly increase the cell survival in primary kidney cell cultures exposed to oxidative stress, possibly involving interaction with the endogenous scavenger system, it failed to influence the viability of normal or cancerous hepatocytes.

Original languageEnglish
Pages (from-to)67-75
Number of pages9
JournalJournal of Molecular Neuroscience
Volume43
Issue number1
DOIs
Publication statusPublished - Jan 2011

Fingerprint

Pituitary Adenylate Cyclase-Activating Polypeptide
Hepatocytes
Oxidative Stress
Cell Death
Kidney
Cell Survival
Superoxide Dismutase
Reperfusion
Ischemia
Primary Cell Culture
Liver
Reperfusion Injury
Malondialdehyde

Keywords

  • Cell survival
  • GSH
  • HEP-G2
  • Hepatocyte
  • Human
  • Ischemia/reperfusion
  • Kidney
  • Rat
  • SOD
  • WRL-68

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells. / Horvath, Gabriella; Brubel, Reka; Kovacs, Krisztina; Reglodi, D.; Opper, Balazs; Ferencz, A.; Szakaly, Peter; Laszlo, Eszter; Hau, Lidia; Kiss, P.; Tamás, A.; Rácz, B.

In: Journal of Molecular Neuroscience, Vol. 43, No. 1, 01.2011, p. 67-75.

Research output: Contribution to journalArticle

Horvath, Gabriella ; Brubel, Reka ; Kovacs, Krisztina ; Reglodi, D. ; Opper, Balazs ; Ferencz, A. ; Szakaly, Peter ; Laszlo, Eszter ; Hau, Lidia ; Kiss, P. ; Tamás, A. ; Rácz, B. / Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells. In: Journal of Molecular Neuroscience. 2011 ; Vol. 43, No. 1. pp. 67-75.
@article{75b1f8172d1b47cb8e37d9f423410619,
title = "Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells",
abstract = "Oxidative stress plays an important role in various renal and hepatic pathologies, and reduction of oxidative stress-induced processes is an important protective strategy in tissues of diverse origins against harmful stimuli. Pituitary adenylate cyclase activating polypeptide (PACAP) is a well-known cytotrophic and cytoprotective peptide. PACAP promotes cell survival in numerous cells and tissues exposed to various stimuli. Protective effects of PACAP have been shown in the kidney, but it is not known whether PACAP is protective against oxidative stress in renal cells. Little is known about the effects of PACAP in the liver. The aim of the present study was to investigate whether PACAP is protective against oxidative stress in primary rat kidney cell culture and whether PACAP has any effect on cell survival in human WRL-68 hepatocytes and HEP-G2 hepatocellular carcinoma cells subjected to oxidative stress. Cells were exposed to various concentrations of H2O2 with or without PACAP co-treatment and cell viability was evaluated with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide test (MTT). We found that oxidative stress induced a significant decrease in cell viability in both cell lines. PACAP could dose-dependently increase the percentage of living cells in kidney cells, but it failed to do so in hepatocytes. Given the survival-promoting effects of PACAP against oxidative stress in rat kidney, we conducted a further experiment to determine whether PACAP influences the markers of oxidative stress in vivo. We have proven earlier that PACAP was effective in kidney ischemia/reperfusion injury in vivo. In the present study, we determined the levels of the oxidative stress marker malondialdehyde and the activity of the scavenger molecules glutathione (GSH) and superoxide dismutase (SOD) following kidney ischemia/reperfusion in rats. We found that PACAP significantly increased the level of GSH and counteracted the marked reduction of SOD activity after ischemia/reperfusion in vivo. In summary, the present study showed that while PACAP was able to significantly increase the cell survival in primary kidney cell cultures exposed to oxidative stress, possibly involving interaction with the endogenous scavenger system, it failed to influence the viability of normal or cancerous hepatocytes.",
keywords = "Cell survival, GSH, HEP-G2, Hepatocyte, Human, Ischemia/reperfusion, Kidney, Rat, SOD, WRL-68",
author = "Gabriella Horvath and Reka Brubel and Krisztina Kovacs and D. Reglodi and Balazs Opper and A. Ferencz and Peter Szakaly and Eszter Laszlo and Lidia Hau and P. Kiss and A. Tam{\'a}s and B. R{\'a}cz",
year = "2011",
month = "1",
doi = "10.1007/s12031-010-9428-8",
language = "English",
volume = "43",
pages = "67--75",
journal = "Journal of Molecular Neuroscience",
issn = "0895-8696",
publisher = "Humana Press",
number = "1",

}

TY - JOUR

T1 - Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells

AU - Horvath, Gabriella

AU - Brubel, Reka

AU - Kovacs, Krisztina

AU - Reglodi, D.

AU - Opper, Balazs

AU - Ferencz, A.

AU - Szakaly, Peter

AU - Laszlo, Eszter

AU - Hau, Lidia

AU - Kiss, P.

AU - Tamás, A.

AU - Rácz, B.

PY - 2011/1

Y1 - 2011/1

N2 - Oxidative stress plays an important role in various renal and hepatic pathologies, and reduction of oxidative stress-induced processes is an important protective strategy in tissues of diverse origins against harmful stimuli. Pituitary adenylate cyclase activating polypeptide (PACAP) is a well-known cytotrophic and cytoprotective peptide. PACAP promotes cell survival in numerous cells and tissues exposed to various stimuli. Protective effects of PACAP have been shown in the kidney, but it is not known whether PACAP is protective against oxidative stress in renal cells. Little is known about the effects of PACAP in the liver. The aim of the present study was to investigate whether PACAP is protective against oxidative stress in primary rat kidney cell culture and whether PACAP has any effect on cell survival in human WRL-68 hepatocytes and HEP-G2 hepatocellular carcinoma cells subjected to oxidative stress. Cells were exposed to various concentrations of H2O2 with or without PACAP co-treatment and cell viability was evaluated with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide test (MTT). We found that oxidative stress induced a significant decrease in cell viability in both cell lines. PACAP could dose-dependently increase the percentage of living cells in kidney cells, but it failed to do so in hepatocytes. Given the survival-promoting effects of PACAP against oxidative stress in rat kidney, we conducted a further experiment to determine whether PACAP influences the markers of oxidative stress in vivo. We have proven earlier that PACAP was effective in kidney ischemia/reperfusion injury in vivo. In the present study, we determined the levels of the oxidative stress marker malondialdehyde and the activity of the scavenger molecules glutathione (GSH) and superoxide dismutase (SOD) following kidney ischemia/reperfusion in rats. We found that PACAP significantly increased the level of GSH and counteracted the marked reduction of SOD activity after ischemia/reperfusion in vivo. In summary, the present study showed that while PACAP was able to significantly increase the cell survival in primary kidney cell cultures exposed to oxidative stress, possibly involving interaction with the endogenous scavenger system, it failed to influence the viability of normal or cancerous hepatocytes.

AB - Oxidative stress plays an important role in various renal and hepatic pathologies, and reduction of oxidative stress-induced processes is an important protective strategy in tissues of diverse origins against harmful stimuli. Pituitary adenylate cyclase activating polypeptide (PACAP) is a well-known cytotrophic and cytoprotective peptide. PACAP promotes cell survival in numerous cells and tissues exposed to various stimuli. Protective effects of PACAP have been shown in the kidney, but it is not known whether PACAP is protective against oxidative stress in renal cells. Little is known about the effects of PACAP in the liver. The aim of the present study was to investigate whether PACAP is protective against oxidative stress in primary rat kidney cell culture and whether PACAP has any effect on cell survival in human WRL-68 hepatocytes and HEP-G2 hepatocellular carcinoma cells subjected to oxidative stress. Cells were exposed to various concentrations of H2O2 with or without PACAP co-treatment and cell viability was evaluated with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide test (MTT). We found that oxidative stress induced a significant decrease in cell viability in both cell lines. PACAP could dose-dependently increase the percentage of living cells in kidney cells, but it failed to do so in hepatocytes. Given the survival-promoting effects of PACAP against oxidative stress in rat kidney, we conducted a further experiment to determine whether PACAP influences the markers of oxidative stress in vivo. We have proven earlier that PACAP was effective in kidney ischemia/reperfusion injury in vivo. In the present study, we determined the levels of the oxidative stress marker malondialdehyde and the activity of the scavenger molecules glutathione (GSH) and superoxide dismutase (SOD) following kidney ischemia/reperfusion in rats. We found that PACAP significantly increased the level of GSH and counteracted the marked reduction of SOD activity after ischemia/reperfusion in vivo. In summary, the present study showed that while PACAP was able to significantly increase the cell survival in primary kidney cell cultures exposed to oxidative stress, possibly involving interaction with the endogenous scavenger system, it failed to influence the viability of normal or cancerous hepatocytes.

KW - Cell survival

KW - GSH

KW - HEP-G2

KW - Hepatocyte

KW - Human

KW - Ischemia/reperfusion

KW - Kidney

KW - Rat

KW - SOD

KW - WRL-68

UR - http://www.scopus.com/inward/record.url?scp=79951576697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951576697&partnerID=8YFLogxK

U2 - 10.1007/s12031-010-9428-8

DO - 10.1007/s12031-010-9428-8

M3 - Article

C2 - 20676802

AN - SCOPUS:79951576697

VL - 43

SP - 67

EP - 75

JO - Journal of Molecular Neuroscience

JF - Journal of Molecular Neuroscience

SN - 0895-8696

IS - 1

ER -